34 - Neha Sabharwal - Panacea Biotech
34 - Neha Sabharwal - Panacea Biotech
34 - Neha Sabharwal - Panacea Biotech
2006-
Submitted to:
Dr. Karamjeet Singh
s for Panacea Biotech
2006- 2009
Submitted by:
Name Neha Sabharwal
Roll No. 34
Class MBA Biotech (A)
BALANCE SHEET 2006 2007 2008 2009
Current Assets:
Cash 44,145.73 15,712.41 14,118.02 5,948.09
Marketable Securities
Accounts Receivable 7,745.35 9,291.60 14,826.08 12,388.01
Inventories 18,389.50 21,043.09 21,459.71 45,324.21
Total Current Assets
Gross Fixed Assets (at cost):
Land & Buildings 5,742.60 10,343.01 12,397.87 21605.19
Machinery and Equipment 12,668.49 20,752.07 25,628.16 42386.71
Furniture & Fixtures 1,609.42 4,670.84 5,510.73 6597.78
Vehicles 840.95 1,095.84 1,195.94 1388.11
Other (Inc. Fin. Leases) 946.72 1,403.87 1,848.29 2,134
Total Gross Fixed Assets 21,808.18 38,265.63 46,580.99 74,111.69
Less: Accumulated Depreciation 7,107.25 10,533.34 14,760.40 21,700.81
Net Fixed Assets 14,700.93 27,732.29 31,820.59 52,410.88
Other Assets 17,079.01 29,465.79 46,154.41 52,630.33
Total Assets 102,060.52 103,245.18 128,378.81 168,701.52
DUPONT ANALYSIS
Net Profit AT/Sales Err:522 Err:522 Err:522 Err:522
Sales/Total Assets Err:522 Err:522 Err:522 Err:522
ROA Err:522 Err:522 Err:522 Err:522
Net Profit AT/Total Assets Err:522 Err:522 Err:522 Err:522
THE COMPANY HAS WITNESSED A DECREASE IN THE LIQUIDITY RATIO WHICH HAS AN
ULTIMATE IMPACT ON THEIR DEBT PAYING CAPACITY AND WORTHYNESS
2.54
2.50
2.45
2.00
1.81 1.78
1.50 Current
1.46 Ratio
Quick Ratio
1.28
1.00 0.97
0.50
0.37
0.00
1 2 3 4
70.00%
Although they have witnessed an incerase in their gross profit but they have decreasing net margin may be
due to higher operating profits
61.12%
60.00%
58.08%
56.57%
51.43%
50.00%
40.00%
30.00%
Gross Profit Margin
26.25% Operating Profit
23.67% Margin
20.00% 20.89% Net Profit Margin
17.04%
15.35%
11.21%
10.00%
0.00%
1 2 3 4
-7.21%
-8.64%
-10.00%
-20.00%
30.00%
After recession in 2007 they have countinuously witness a
27.23% decrease in their return on equity and return on assets again
imphasizing their net profit margin
25.00%
24.30%
20.00%
18.92%
15.00%
14.22%
10.00% 10.37%
Return on assets
Return on
5.97% Equity
5.00%
0.00%
1 2 3 4
-4.09%
-5.00%
-10.00%
-11.10%
-15.00%
D-E Ratio
2.00
Over the yeras they have again increased their debt in
their capital mix may be in an effort to reduce their cost of
1.80 1.79 capital
1.60
1.40
1.20
1.00 D-E
Ratio
0.87
0.80
0.60
0.47
0.40
0.37
0.20
0.00
1 2 3 4